natgillin/translations-raw huggingface dataset:
On 29 May 2017, the EU Military Committee recommended that the PSC appoint Brigadier General Bart LAURENT to succeed Brigadier General Peter DEVOGELAERE as the EU Mission Force Commander of EUTM Mali as from 12 July 2017.
Vojaški odbor EU je 29. maja 2017 priporočil, da PVO imenuje brigadnega generala Barta LAURENTA, ki bi na mestu poveljnika sil misije EU za EUTM Mali od 12. julija 2017 nasledil brigadnega generala Petra DEVOGELAEREJA.
Brigadier General Bart LAURENT is hereby appointed as the EU Mission Force Commander of the European Union military mission to contribute to the training of the Malian Armed Forces (EUTM Mali) as from 12 July 2017.
Brigadni general Bart LAURENT se z 12. julijem 2017 imenuje za poveljnika sil misije EU v vojaški misiji Evropske unije, ki prispeva k usposabljanju malijskih oboroženih sil (EUTM Mali).
Political and Security Committee Decision (CFSP) 2016/2352 of 7 December 2016 on the appointment of the EU Mission Commander for the European Union military mission to contribute to the training of the Malian Armed Forces (EUTM Mali) and repealing Decision (CFSP) 2016/939 (EUTM Mali/2/2016) (OJ L 348, 21.12.2016, p. 25).
Sklep Političnega in varnostnega odbora (SZVP) 2016/2352 z dne 7. decembra 2016 o imenovanju poveljnika misije EU v vojaški misiji Evropske unije, ki prispeva k usposabljanju malijskih oboroženih sil (EUTM Mali), in razveljavitvi Sklepa (SZVP) 2016/939 (EUTM Mali/2/2016) (UL L 348, 21.12.2016, str. 25).
Council Decision (EU) 2017/971 of 8 June 2017 determining the planning and conduct arrangements for EU non-executive military CSDP missions and amending Decisions 2010/96/CFSP on a European Union military mission to contribute to the training of Somali security forces, 2013/34/CFSP on a European Union military mission to contribute to the training of the Malian armed forces (EUTM Mali) and (CFSP) 2016/610 on a European Union CSDP military training mission in the Central African Republic (EUTM RCA) (OJ L 146, 9.6.2017, p. 133).
Sklep Sveta (EU) 2017/971 z dne 8. junija 2017 o ureditvah za načrtovanje in izvajanje vojaških misij EU, v okviru SVOP, brez izvršilnih pooblastil ter o spremembi sklepov 2010/96/SZVP o vojaški misiji Evropske unije, ki prispeva k usposabljanju somalskih varnostnih sil, 2013/34/SZVP o vojaški misiji Evropske unije, ki prispeva k usposabljanju malijskih oboroženih sil (EUTM Mali) in (SZVP) 2016/610 o misiji Evropske unije za vojaško usposabljanje v okviru SVOP v Srednjeafriški republiki (EUTM RCA) (UL L 146, 9.6.2017, str. 133).
Political and Security Committee Decision (CFSP) 2017/1177
Sklep Političnega in varnostnega odbora (SZVP) 2017/1177
on the appointment of the EU Mission Force Commander of the European Union CSDP Military Training Mission in the Central African Republic (EUTM RCA) (EUTM RCA/2/2017)
o imenovanju poveljnika sil misije EU v misiji Evropske unije za vojaško usposabljanje v okviru SVOP v Srednjeafriški republiki (EUTM RCA) (EUTM RCA/2/2017)
Having regard to the Treaty on European Union, and in particular Article 38 thereof,
ob upoštevanju Pogodbe o Evropski uniji in zlasti člena 38 Pogodbe,
Having regard to Council Decision (CFSP) 2016/610 of 19 April 2016 on a European Union CSDP Military Training Mission in the Central African Republic (EUTM RCA) [1], and in particular Article 5 thereof,
ob upoštevanju Sklepa Sveta (SZVP) 2016/610 z dne 19. aprila 2016 o misiji Evropske unije za vojaško usposabljanje v okviru SVOP v Srednjeafriški republiki (EUTM RCA) [1] in zlasti člena 5 Sklepa,
Pursuant to Article 5(1) of Decision (CFSP) 2016/610, the Council authorised the Political and Security Committee (PSC), in accordance with Article 38 of the Treaty on European Union, to take the relevant decisions concerning the political control and strategic direction of EUTM RCA, including the decisions on the appointment of subsequent EU Mission Commanders.
Svet je na podlagi člena 5(1) Sklepa (SZVP) 2016/610 pooblastil Politični in varnostni odbor (PVO), da v skladu s členom 38 Pogodbe o Evropski uniji sprejme ustrezne odločitve glede političnega nadzora in strateškega vodenja EUTM RCA, vključno s sklepi o imenovanju naslednjih poveljnikov misije EU.
On 10 January 2017, the PSC adopted Decision (CFSP) 2017/112 [2] appointing Brigadier General Herman RUYS as the EU Mission Commander of EUTM RCA.
PVO je 10. januarja 2017 sprejel Sklep (SZVP) 2017/112 [2], s katerim je za poveljnika misije EU za EUTM RCA imenoval brigadnega generala Hermana RUYSA.
Council Decision (EU) 2017/971 [3] amended the chain of command of EUTM RCA.
Sklep Sveta (EU) 2017/971 [3] je spremenil linijo poveljevanja EUTM RCA.
Consequently, Decision (CFSP) 2017/112 was repealed, and Brigadier General Herman RUYS was appointed as the EU Mission Force Commander of EUTM RCA.
Sklep (SZVP) 2017/112 je bil zato razveljavljen in brigadni general Herman RUYS je bil imenovan za poveljnika sil misije EU za EUTM RCA.
On 24 May 2017, the EU Military Committee recommended the approval of the nomination of Brigadier General Fernando GARCÍA BLÁZQUEZ, proposed by the Eurocorps Common Committee, to succeed Brigadier General Herman RUYS as the EU Mission Force Commander of EUTM RCA as from 24 July 2017.
Vojaški odbor EU je 24. maja 2017 priporočil, da se odobri predlog Skupnega odbora Eurocorps o imenovanju brigadnega generala Fernanda GARCÍE BLÁZQUEZA, ki bi na mestu poveljnika sil misije EUTM RCA od 24. julija 2017 nasledil brigadnega generala Hermana RUYSA.
In accordance with Article 5 of Protocol No 22 on the position of Denmark, annexed to the Treaty on European Union and to the Treaty on the Functioning of the European Union, Denmark does not participate in the elaboration and the implementation of decisions and actions of the Union which have defence implications.
V skladu s členom 5 Protokola št. 22 o stališču Danske, ki je priložen Pogodbi o Evropski uniji in Pogodbi o delovanju Evropske unije, Danska ne sodeluje pri pripravi in izvajanju sklepov in ukrepov Unije, ki zadevajo obrambo.
Consequently, Denmark is not participating in the adoption of this Decision and is neither bound by it nor subject to its application,
Danska zato ne sodeluje pri sprejetju tega sklepa, ki zanjo ni zavezujoč in se v njej ne uporablja –
Brigadier General Fernando GARCÍA BLÁZQUEZ is hereby appointed as the EU Mission Force Commander of the European Union CSDP Military Training Mission in the Central African Republic (EUTM RCA) as from 24 July 2017.
Brigadni general Fernando GARCÍA BLÁZQUEZ se s 24. julijem 2017 imenuje za poveljnika sil misije EU v misiji Evropske unije za vojaško usposabljanje v okviru SVOP v Srednjeafriški republiki (EUTM RCA).
Political and Security Committee Decision (CFSP) 2017/112 of 10 January 2017 appointing the EU Mission Commander for the European Union CSDP Military Training Mission in the Central African Republic (EUTM RCA) (EUTM RCA/1/2017) (OJ L 18, 24.1.2017, p. 47).
Sklep Političnega in varnostnega odbora (SZVP) 2017/112 z dne 10. januarja 2017 o imenovanju poveljnika misije EU v misiji Evropske unije za vojaško usposabljanje v okviru SVOP v Srednjeafriški republiki (EUTM RCA) (EUTM RCA/1/2017) (UL L 18, 24.1.2017, str. 47).
Commission Implementing Decision (EU) 2017/1178
Izvedbeni sklep Komisije (EU) 2017/1178
of 2 June 2017
z dne 2. junija 2017
amending Implementing Decision (EU) 2016/2008 concerning animal health control measures relating to lumpy skin disease in certain Member States
o spremembi Izvedbenega sklepa (EU) 2016/2008 o nadzornih ukrepih za zdravje živali v zvezi z vozličastim dermatitisom v nekaterih državah članicah
(notified under document C(2017) 3624)
(notificirano pod dokumentarno številko C(2017) 3624)
Having regard to Council Directive 92/119/EEC of 17 December 1992 introducing general Community measures for the control of certain animal diseases and specific measures relating to swine vesicular disease [3], and in particular Article 19(1)(a) and (3)(a) and Article 19(6) thereof,
ob upoštevanju Direktive Sveta 92/119/EGS z dne 17. decembra 1992 o splošnih ukrepih Skupnosti za nadzor nad določenimi živalskimi boleznimi in o posebnih ukrepih v primeru vezikularne bolezni prašičev [3] ter zlasti člena 19(1)(a) in 3(a) ter člena 19(6) Direktive,
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down the animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption [4], and in particular Article 4(3) thereof,
ob upoštevanju Direktive Sveta 2002/99/ES z dne 16. decembra 2002 o predpisih v zvezi z zdravstvenim varstvom živali, ki urejajo proizvodnjo, predelavo, distribucijo in uvoz proizvodov živalskega izvora, namenjenih prehrani ljudi [4], ter zlasti člena 4(3) Direktive,
These control measures include the establishment of protection and surveillance zones around the infected holding, and they also provide for emergency vaccination in the event of an outbreak of LSD.
Ti nadzorni ukrepi vključujejo vzpostavitev okuženih in ogroženih območij okoli okuženega gospodarstva ter zagotavljajo tudi cepljenje v izrednih razmerah v primeru izbruha vozličastega dermatitisa.
Commission Implementing Decision (EU) 2016/2008 [5] lays down animal health control measures in relation to the occurrence of LSD in the Member States or parts thereof as listed in Annex I thereto, including the minimum requirements for vaccination programmes against that disease submitted by the Member States to the Commission for approval.
Izvedbeni sklep Komisije (EU) 2016/2008 [5] določa nadzorne ukrepe za zdravje živali v zvezi s pojavom vozličastega dermatitisa v državah članicah ali njihovih delih, kot so navedeni v Prilogi I k navedenemu sklepu, vključno z minimalnimi zahtevami za programe cepljenja proti navedeni bolezni, ki jih Komisiji v odobritev predložijo države članice.
Article 2 of Implementing Decision (EU) 2016/2008 defines an ‘infected zone’ as being the part of the territory of a Member State listed in Part II of Annex I thereto, which includes the area where LSD was confirmed, and where vaccination against LSD may be implemented following the approval of vaccination programmes by the Commission.
Člen 2 Izvedbenega sklepa (EU) 2016/2008 opredeljuje „okuženo območje“ kot del ozemlja države članice iz dela II Priloge I k navedenemu sklepu, ki vključuje območje, na katerem je bil potrjen vozličasti dermatitis, in kjer se cepljenje proti vozličastemu dermatitisu lahko izvaja po odobritvi programov cepljenja s strani Komisije.
Article 2 of that Implementing Decision also defines a ‘free zone with vaccination’ as being the part of the territory of a Member State listed in Part I of Annex I thereto, which includes the areas outside the infected zones, where vaccination against LSD is implemented following the approval of vaccination programmes by the Commission.
Člen 2 navedenega izvedbenega sklepa opredeljuje tudi „prosto območje s cepljenjem“ kot del ozemlja države članice iz dela I Priloge I k navedenemu sklepu, ki vključuje območja zunaj okuženih območij, kjer se cepljenje proti vozličastemu dermatitisu izvaja po odobritvi programov cepljenja s strani Komisije.
Article 3 of Implementing Decision (EU) 2016/2008 lays down restrictions on the dispatch of bovine animals and captive wild ruminants and certain animal products from the areas listed in Annex I thereto, with a view to minimise any risk of the spread of LSD.
Člen 3 Izvedbenega sklepa (EU) 2016/2008 določa omejitve glede odpreme goveda in divjih prežvekovalcev v ujetništvu ter nekaterih živalskih proizvodov z območij iz Priloge I k navedenemu sklepu, da bi se zmanjšalo kakršno koli tveganje širjenja vozličastega dermatitisa.
Article 7 of Implementing Decision (EU) 2016/2008 provides for derogations from the restrictions laid down in Article 3 of that Implementing Decision relating to the dispatch of semen, ova and embryos of bovine animals and captive wild ruminants from the areas listed as free zones with vaccination in Part I of Annex I thereto.
Člen 7 Izvedbenega sklepa (EU) 2016/2008 določa odstopanja od omejitev iz člena 3 navedenega izvedbenega sklepa v zvezi z odpremo semena, jajčnih celic in zarodkov goveda in divjih prežvekovalcev v ujetništvu z območij, navedenih kot prosta območja s cepljenjem v delu I Priloge I k navedenemu sklepu.
It is appropriate to differentiate the level of risk for the spread of LSD through consignments of semen, ova and embryos when such germinal products are dispatched from a free zone with vaccination to another free zone with vaccination or to an infected zone located within the same Member State.
Ustrezno je razlikovati med stopnjami tveganja za širjenje vozličastega dermatitisa prek pošiljk semena, jajčnih celic in zarodkov, kadar se tak zarodni material odpremi s prostega območja s cepljenjem na drugo prosto območje s cepljenjem ali na okuženo območje, ki je v isti državi članici.
It is therefore necessary to establish separate conditions, which are proportionate to the risks involved, for derogations that apply to such consignments that remain within the same Member State provided that such conditions are in place for the safe dispatch of such germinal products within the free zone with vaccination or the infected zone of the same Member State.
Zato je treba vzpostaviti ločene pogoje, sorazmerne s tveganji, za odstopanja, ki se uporabljajo za take pošiljke, ki ostanejo v isti državi članici, če so taki pogoji uvedeni za varno odpremo takega zarodnega materiala znotraj prostega območja s cepljenjem ali okuženega območja, ki je v isti državi članici.
Article 7 of Implementing Decision (EU) 2016/2008 should therefore be amended accordingly.
Člen 7 Izvedbenega sklepa (EU) 2016/2008 bi bilo zato treba ustrezno spremeniti.
On 2 March 2017, Greece reported a new outbreak of LSD in the regional unit of Kerkyra, an island in the Ionian Sea, at the most North West part of Greece, where no outbreaks of LSD have previously been reported.
Dne 2. marca 2017 je Grčija poročala o novem izbruhu vozličastega dermatitisa v regionalni enoti Kerkyra (otoku v Jonskem morju na skrajnem severozahodu Grčije), iz katere do zdaj niso poročali o izbruhih vozličastega dermatitisa.
For this reason, the infected zones of Greece, in relation to LSD, listed in Part II of Annex I to Implementing Decision (EU) 2016/2008, should be expanded to include the regional unit of Kerkyra.
Zaradi tega bi bilo treba razširiti okužena območja Grčije iz dela II Priloge I k Izvedbenemu sklepu (EU) 2016/2008 v povezavi z vozličastim dermatitisom, da bi se vključila regionalna enota Kerkyra.
Part II of Annex I to Implementing Decision (EU) 2016/2008 should therefore be amended accordingly.
Del II Priloge I k Izvedbenemu sklepu (EU) 2016/2008 bi bilo zato treba ustrezno spremeniti.
On 14 March 2017, Greece informed the Commission of its decision to expand vaccination against LSD in the regions of the Ionian Islands, the North and South Aegean and Crete, areas where LSD has not occurred to date, except for the regional unit of Kerkyra where the disease was confirmed on 2 March 2017, and the regional unit of Limnos where the disease has been present since 2015.
Dne 14. marca 2017 je Grčija obvestila Komisijo o svoji odločitvi, da bo povečala precepljenost proti vozličastemu dermatitisu v regijah Jonski otoki, Severni in Južni Egejski otoki ter Kreta, tj. na območjih, kjer se do zdaj vozličasti dermatitis ni pojavil, razen v regionalni enoti Kerkyra, kjer je bila bolezen potrjena 2. marca 2017, in v regionalni enoti Limnos, kjer je bolezen prisotna od leta 2015.
For this reason, those regions of Greece should be included in the free zones with vaccination, listed in Part I of Annex I to Implementing Decision (EU) 2016/2008.
Zato bi bilo treba navedene regije Grčije vključiti v prosta območja s cepljenjem, navedena v delu I Priloge I k Izvedbenemu sklepu (EU) 2016/2008.
Part I of Annex I to Implementing Decision (EU) 2016/2008 should therefore be amended accordingly.
Del I Priloge I k Izvedbenemu sklepu (EU) 2016/2008 bi bilo zato treba ustrezno spremeniti.
Implementing Decision (EU) 2016/2008 is amended as follows:
Izvedbeni sklep (EU) 2016/2008 se spremeni:
Derogations from the prohibition on the dispatch of semen, ova and embryos of bovine animals and captive wild ruminants from the areas listed in Parts I and II of Annex I and special conditions for the dispatch of those products within the areas listed in Part I or II of the same Member State
Odstopanja od prepovedi odpreme semena, jajčnih celic in zarodkov goveda in divjih prežvekovalcev v ujetništvu z območij iz delov I in II Priloge I ter posebni pogoji za odpremo navedenih proizvodov znotraj območij iz dela I ali II v isti državi članici
By way of derogation from the prohibition provided for in point (b) of Article 3, the competent authority may authorise the dispatch of semen, ova and embryos of bovine animals and captive wild ruminants from semen collection centres or other establishments situated in an area listed in Part I of Annex I to another area listed in Part I or II of Annex I of another Member State provided that the donor animals and the semen, ova and embryos comply with the following conditions:
Z odstopanjem od prepovedi iz točke (b) člena 3 lahko pristojni organ odobri odpremo semena, jajčnih celic in zarodkov goveda in divjih prežvekovalcev v ujetništvu iz osemenjevalnih središč ali drugih obratov na območju iz dela I Priloge I na drugo območje iz dela I ali II Priloge I v drugi državi članici, če živali darovalke ter semena, jajčne celice in zarodki izpolnjujejo naslednje pogoje:
the donor animals were vaccinated and revaccinated against lumpy skin disease according to the manufacturer's instructions of the vaccine used, the first vaccination being administrated at least 60 days prior to the date of collection of the semen, ova or embryo; or the donor animals were subjected to a serological test to detect specific antibodies against lumpy skin disease virus on the day of the collection and at least 28 days after the semen collection period or the day of collection for embryos and ova, with negative results;
živali darovalke so bile cepljene in ponovno cepljene proti vozličastemu dermatitisu v skladu z navodili proizvajalca uporabljenega cepiva, prvo cepljenje pa je bilo izvedeno najmanj 60 dni pred datumom odvzema semena, jajčnih celic ali zarodkov; ali živali darovalke so bile pregledane s serološkim testom za odkrivanje protiteles, specifičnih za virus vozličastega dermatitisa, na dan odvzema in vsaj 28 dni po obdobju odvzema semena ali na dan zbiranja jajčnih celic in zarodkov, z negativnimi rezultati;
the donor animals were kept, during the 60 days prior to the date of collection of the semen, ova or embryos, in an artificial insemination centre or other appropriate establishment where, in a radius of at least 20 km, no presence of lumpy skin disease has been confirmed during the three months prior to the date of collection of the semen, ova or embryos and before that any confirmation of infection with lumpy skin disease was subject to culling and destruction of all susceptible animals on the affected holdings;
živali darovalke so bile v 60 dneh pred datumom odvzema semena, jajčnih celic ali zarodkov v osemenjevalnem središču ali drugem ustreznem obratu, kjer v polmeru vsaj 20 km ni bila potrjena prisotnost vozličastega dermatitisa v treh mesecih pred datumom odvzema semena, jajčnih celic ali zarodkov, pred odpremo pa sta vsaki potrditvi okužbe z vozličastim dermatitisom sledila izločitev in uničenje vseh okuženih dovzetnih živali na prizadetih gospodarstvih;
the donor animals were clinically checked 28 days prior to the date of collection, as well as throughout the entire collection period, and did not show any clinical symptoms of lumpy skin disease;
živali darovalke so bile klinično pregledane 28 dni pred datumom odvzema kot tudi skozi celotno obdobje odvzemov in niso kazale nobenih kliničnih znakov vozličastega dermatitisa;
the donor animals were subjected to lumpy skin disease agent detection by polymerase chain reaction (PCR) conducted on blood samples collected at the commencement and at least every 14 days thereafter during the semen collection period or on the day of collection for embryos and ova, with negative results;
živali darovalke so bile pregledane na prisotnost povzročitelja vozličastega dermatitisa z verižno reakcijo s polimerazo (PCR) na krvnih vzorcih, odvzetih na začetku in nato najmanj vsakih 14 dni med obdobjem odvzema semena ali na dan odvzema jajčnih celic in zarodkov, in sicer z negativnimi rezultati;
the semen was subjected to lumpy skin disease agent detection by PCR with negative results; and
seme je bilo pregledano za prisotnost povzročitelja vozličastega dermatitisa z verižno reakcijo s polimerazo (PCR), in sicer z negativnimi rezultati, ter
the competent authority at the place of origin is implementing a vaccination programme against lumpy skin disease, which complies with the conditions laid down in Annex II and which has been approved by the Commission and it has informed the Commission and the other Member States of the commencement date and the completion date of its vaccination programme in accordance with Annex II.
pristojni organ v državi izvora izvaja program cepljenja proti vozličastemu dermatitisu, ki izpolnjuje pogoje iz Priloge II in ga je odobrila Komisija, in je obvestil Komisijo in druge države članice o datumu začetka in zaključka svojega programa cepljenja v skladu s Prilogo II.
By way of derogation from the prohibition provided for in point (b) of Article 3, the competent authority may authorise the dispatch of semen, ova and embryos of bovine animals and captive wild ruminants from semen collection centres or other establishments situated in an area listed in:
Z odstopanjem od prepovedi iz točke (b) člena 3 lahko pristojni organ odobri odpremo semena, jajčnih celic in zarodkov goveda in divjih prežvekovalcev v ujetništvu iz osemenjevalnih središč ali drugih obratov na območju iz:
Part I of Annex I to a destination situated within another area listed in Part I or II of Annex I of the same Member State;
dela I Priloge I v namembni kraj, ki je na drugem območju iz dela I ali II Priloge I v isti državi članici;
Part II of Annex I to a destination situated within another area listed in Part II of Annex I of the same Member State.
dela II Priloge I v namembni kraj, ki je na drugem območju iz dela II Priloge I v isti državi članici.
The derogation provided for in the first subparagraph of this paragraph is subject to compliance with the conditions laid down in paragraph 1(a), (b) and (c);
Odstopanje iz prvega pododstavka tega odstavka se uporablja pod pogojem, da so izpolnjeni pogoji iz odstavka 1(a), (b) in (c).
By way of derogation from the prohibition provided for in point (b) of Article 3, the competent authority may authorise the dispatch of semen, ova and embryos of bovine animals and captive wild ruminants from semen collection centres or other establishments situated in the areas listed in Part I of Annex I to any area of the same or another Member State or to a third country provided that the donor animals and the semen, ova and embryos comply with the following conditions:
Z odstopanjem od prepovedi iz točke (b) člena 3 lahko pristojni organ odobri odpremo semena, jajčnih celic in zarodkov goveda in divjih prežvekovalcev v ujetništvu iz osemenjevalnih središč ali drugih obratov na območjih iz dela I Priloge I na katero koli območje v isti ali drugi državi članici ali v tretjo državo, če živali darovalke ter semena, jajčne celice in zarodki izpolnjujejo naslednje pogoje:
the conditions laid down in paragraph 1(a) to (f);
pogoje iz odstavka 1(a) do (f);